CliffBio
small molecule

DUOCAINE

BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmphastar Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameDUOCAINE
Active ingredientBUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE
StrengthEQ 0.375% (37.5MG/10ML);EQ 1% (100MG/10ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2003
Marketing statusDISCN

More from Amphastar Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DUOCAINE patent cliff — loss of exclusivity — | CliffBio